NIH-funded research R21 grant

Investigating how Vibrio vulnificus bacteria cause infections in skin wounds

Official title: Ex vivo skin wound infection model for Vibrio vulnificus pathogenesis

Funded at Trustees of Indiana University · NIH-11094072 · Data updated 2026-11-12

This study is looking at how Vibrio vulnificus bacteria cause infections in skin wounds and aims to find new ways to treat these infections, especially for people who have antibiotic-resistant strains.

More Wound research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionTrustees of Indiana University
NIH-funded
Lab location1 site (Bloomington, United States)
Project startMay 23, 2024
Project endMarch 31, 2026
Funding year2025
Award (this year)$189,699
NIH project number5R21AI182897-02
Project IDNIH-11094072 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with skin wounds who are at risk of Vibrio infections, particularly those living in coastal areas or with exposure to marine environments.

Less likely to help

Patients who do not have skin wounds or are not at risk of Vibrio infections may not benefit from this research.

What this research studies

This research focuses on understanding the mechanisms by which Vibrio vulnificus bacteria lead to infections, particularly in skin wounds. The study utilizes an ex vivo model to explore the role of quorum sensing, a communication method used by bacteria to coordinate their behavior. By targeting specific proteins involved in this process, the research aims to develop new therapeutic strategies that could effectively combat antibiotic-resistant strains of Vibrio. Patients may benefit from insights that could lead to innovative treatments for infections caused by these bacteria.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for infections caused by antibiotic-resistant Vibrio bacteria, improving patient outcomes.

How similar studies have gone: Previous research has shown promise in targeting quorum sensing in bacteria, indicating that this approach could be effective in developing new treatments.

Where this research is happening

  • Trustees of Indiana University
    Bloomington, United States
    Active

Researchers

  • Principal investigator: Van Kessel, Julia C. — Trustees of Indiana University
  • Study coordinator: Van Kessel, Julia C.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.